{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:51:28Z","timestamp":1792065088597,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":249,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NAM Journal"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.namjnl.2026.100129","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:35:09Z","timestamp":1788824109000},"page":"100129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From vivarium to NAM-centred laboratory: A practical framework for managing infrastructure, expertise and organisational transition"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0777-7969","authenticated-orcid":false,"given":"Clive","family":"Roper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5510-6852","authenticated-orcid":false,"given":"Michael D.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.namjnl.2026.100129_bib0001","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"issue":"10","key":"10.1016\/j.namjnl.2026.100129_bib0002","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41416-020-01033-x","article-title":"Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials","volume":"123","author":"Atkins","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.namjnl.2026.100129_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104662","article-title":"An FDA\/CDER perspective on nonclinical testing strategies: classical toxicology approaches and new approach methodologies (NAMs)","volume":"114","author":"Avila","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.namjnl.2026.100129_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105345","article-title":"Gaps and challenges in nonclinical assessments of pharmaceuticals: an FDA\/CDER perspective on considerations for development of new approach methodologies","volume":"139","author":"Avila","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.namjnl.2026.100129_bib0005","author":"\u010cavo\u0161ki"},{"key":"10.1016\/j.namjnl.2026.100129_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150225","article-title":"Machine learning and related approaches in transcriptomics","volume":"724","author":"Cheng","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.namjnl.2026.100129_bib0008","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/bios14050225","article-title":"A Comprehensive Review of Organ-on-a-Chip Technology and Its Applications","volume":"14","author":"Farhang Doost","year":"2024","journal-title":"Biosensors"},{"key":"10.1016\/j.namjnl.2026.100129_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.namjnl.2026.100119","article-title":"Need for NAMs: a systematic evidence synthesis revealing over half a century of drug development failure","volume":"2","author":"Filipova","year":"2026","journal-title":"NAM J."},{"issue":"8","key":"10.1016\/j.namjnl.2026.100129_bib0010","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3390\/ph17081048","article-title":"The pivotal role of preclinical animal models in anti-cancer drug discovery and personalized cancer therapy strategies","volume":"17","author":"Guo","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.namjnl.2026.100129_bib0012","series-title":"FDA Modernization Act of 2021; 117th Congress (2021\u20132022)","year":"2022"},{"key":"10.1016\/j.namjnl.2026.100129_bib0013","unstructured":"H.R.2821, 2022. FDA Modernization Act 3.0; 119th Congress. U.S. Congress Website https:\/\/www.govtrack.us\/congress\/bills\/119\/hr2821\/text. Accessed 19 August 2026."},{"issue":"5","key":"10.1016\/j.namjnl.2026.100129_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036098","article-title":"NT2 derived neuronal and astrocytic network signalling","volume":"7","author":"Hill","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.namjnl.2026.100129_bib0014","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202256485","article-title":"Replacing mammals in drug development: Non-mammalian models accelerate translational and pre-clinical research: non-mammalian models accelerate translational and pre-clinical research","volume":"24","author":"Hunter","year":"2023","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.namjnl.2026.100129_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/02611929241310566","article-title":"The use of MPS in Three Rs and regulatory applications: perspectives from developers on stakeholder responsibilities","volume":"53","author":"LaFollette","year":"2025","journal-title":"Altern. Lab. Anim. (ATLA)"},{"key":"10.1016\/j.namjnl.2026.100129_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.namjnl.2026.100085","article-title":"Never-ending Acronym Madness: proposing a harmonized definition for NAMs","author":"LaFollette","year":"2026","journal-title":"NAM J."},{"key":"10.1016\/j.namjnl.2026.100129_bib0017","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43586-022-00118-6","article-title":"A guide to the organ-on-a-chip","volume":"2","author":"Leung","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"issue":"2","key":"10.1016\/j.namjnl.2026.100129_bib0018","first-page":"373","article-title":"Lost in NAMs-lation: a review of animal-free science definitions","volume":"43","author":"Macmillan","year":"2026","journal-title":"ALTEX"},{"issue":"8","key":"10.1016\/j.namjnl.2026.100129_bib0019","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00204-024-03802-6","article-title":"Time for CHANGE: system-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology","volume":"98","author":"Mathisen","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.namjnl.2026.100129_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105904","article-title":"A call to action: advancing new approach methodologies (NAMs) in regulatory toxicology through a unified framework for validation and acceptance","volume":"162","author":"Ouedraogo","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"15","key":"10.1016\/j.namjnl.2026.100129_bib0022","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1039\/D1LC00241D","article-title":"Standardisation needs for organ on chip devices","volume":"21","author":"Piergiovanni","year":"2021","journal-title":"Lab Chip"},{"issue":"4","key":"10.1016\/j.namjnl.2026.100129_bib0023","doi-asserted-by":"crossref","DOI":"10.1063\/5.0011583","article-title":"Organ-on-a-chip engineering: toward bridging the gap between lab and industry","volume":"14","author":"Ramadan","year":"2020","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.namjnl.2026.100129_bib0025","article-title":"Case study on the use of an Integrated Approach for Testing and Assessment (IATA) for New Approach Methodology (NAM) for refining inhalation risk assessment from point of contact toxicity of the pesticide, chlorothalonil. ENV\/CBC\/MONO(2022)31","volume":"367","author":"Roper","year":"2022","journal-title":"OECD Environ. Health Saf. Publ. Ser. Test. Assess. No,"},{"key":"10.1016\/j.namjnl.2026.100129_bib32","doi-asserted-by":"crossref","unstructured":"Sewell F., Alexander-White C., Brescia S., Currie R.A., Roberts R., Roper C., Vickers C., Westmoreland C., Kimber I. New approach methodologies (NAMs): identifying and overcoming hurdles to accelerated adoption. Toxicol Res (Camb). 2024 25;13(2):tfae044. doi:10.1093\/toxres\/tfae044.","DOI":"10.1093\/toxres\/tfae044"},{"issue":"4","key":"10.1016\/j.namjnl.2026.100129_bib31","doi-asserted-by":"crossref","first-page":"103496","DOI":"10.1016\/j.drudis.2023.103496","article-title":"The FDA modernisation act 2.0: Bringing non-animal technologies to the regulatory table","volume":"28","author":"Stewart","year":"2023","journal-title":"Drug Discov Today"},{"issue":"7","key":"10.1016\/j.namjnl.2026.100129_bib0026","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.namjnl.2026.100129_bib0027","first-page":"519","article-title":"Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessment","volume":"40","author":"Turner","year":"2023","journal-title":"ALTEX"},{"key":"10.1016\/j.namjnl.2026.100129_bib0029","article-title":"Policy paper. Replacing animals in science: a strategy to support the development","year":"2025","journal-title":"Valid. Uptake Altern. Methods"},{"key":"10.1016\/j.namjnl.2026.100129_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172524","article-title":"Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease","volume":"859","author":"Veening-Griffioen","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"6796","key":"10.1016\/j.namjnl.2026.100129_bib0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.aeb0045","article-title":"Reimagining human-centric drug development with new approach methodologies","volume":"392","author":"Wu","year":"2026","journal-title":"Science"}],"container-title":["NAM Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050620426000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050620426000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:04:07Z","timestamp":1792062247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050620426000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":29,"alternative-id":["S3050620426000540"],"URL":"https:\/\/doi.org\/10.1016\/j.namjnl.2026.100129","relation":{},"ISSN":["3050-6204"],"issn-type":[{"value":"3050-6204","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From vivarium to NAM-centred laboratory: A practical framework for managing infrastructure, expertise and organisational transition","name":"articletitle","label":"Article Title"},{"value":"NAM Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.namjnl.2026.100129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100129"}}